Loading…
Cardiovascular disease/stroke risk stratification in deep learning framework: a review
The global mortality rate is known to be the highest due to cardiovascular disease (CVD). Thus, preventive, and early CVD risk identification in a non-invasive manner is vital as healthcare cost is increasing day by day. Conventional methods for risk prediction of CVD lack robustness due to the non-...
Saved in:
Published in: | Cardiovascular diagnosis and therapy 2023-06, Vol.12 (3), p.557-598 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c382t-177a53fb5df3eae2421e439e9de10b6394f2cd3cdea78d7890fc27dc405b394f3 |
---|---|
cites | |
container_end_page | 598 |
container_issue | 3 |
container_start_page | 557 |
container_title | Cardiovascular diagnosis and therapy |
container_volume | 12 |
creator | Bhagawati, Mrinalini Paul, Sudip Agarwal, Sushant Protogeron, Athanasios Sfikakis, Petros P. Kitas, George D. Khanna, Narendra N. Ruzsa, Zoltan Sharma, Aditya M. Tomazu, Omerzu Turk, Monika Faa, Gavino Tsoulfas, George Laird, John R. Rathore, Vijay Johri, Amer M. Viskovic, Klaudija Kalra, Manudeep Balestrieri, Antonella Nicolaides, Andrew Singh, Inder M. Chaturvedi, Seemant Paraskevas, Kosmas I. Fouda, Mostafa M. Saba, Luca Suri, Jasjit S. |
description | The global mortality rate is known to be the highest due to cardiovascular disease (CVD). Thus, preventive, and early CVD risk identification in a non-invasive manner is vital as healthcare cost is increasing day by day. Conventional methods for risk prediction of CVD lack robustness due to the non-linear relationship between risk factors and cardiovascular events in multi-ethnic cohorts. Few recently proposed machine learning-based risk stratification reviews without deep learning (DL) integration. The proposed study focuses on CVD risk stratification by the use of techniques mainly solo deep learning (SDL) and hybrid deep learning (HDL). Using a PRISMA model, 286 DL-based CVD studies were selected and analyzed. The databases included were Science Direct, IEEE Xplore, PubMed, and Google Scholar. This review is focused on different SDL and HDL architectures, their characteristics, applications, scientific and clinical validation, along with plaque tissue characterization for CVD/stroke risk stratification. Since signal processing methods are also crucial, the study further briefly presented Electrocardiogram (ECG)-based solutions. Finally, the study presented the risk due to bias in AI systems. The risk of bias tools used were (I) ranking method (RBS), (II) region-based map (RBM), (III) radial bias area (RBA), (IV) prediction model risk of bias assessment tool (PROBAST), and (V) risk of bias in non-randomized studies-of interventions (ROBINS-I). The surrogate carotid ultrasound image was mostly used in the UNet-based DL framework for arterial wall segmentation. Ground truth (GT) selection is vital for reducing the risk of bias (RoB) for CVD risk stratification. It was observed that the convolutional neural network (CNN) algorithms were widely used since the feature extraction process was automated. The ensemble-based DL techniques for risk stratification in CVD are likely to supersede the SDL and HDL paradigms. Due to the reliability, high accuracy, and faster execution on dedicated hardware, these DL methods for CVD risk assessment are powerful and promising. The risk of bias in DL methods can be best reduced by considering multicentre data collection and clinical evaluation. |
doi_str_mv | 10.21037/cdt-22-438 |
format | article |
fullrecord | <record><control><sourceid>pubmedcentral_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10315429</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_10315429</sourcerecordid><originalsourceid>FETCH-LOGICAL-c382t-177a53fb5df3eae2421e439e9de10b6394f2cd3cdea78d7890fc27dc405b394f3</originalsourceid><addsrcrecordid>eNpVkM1LAzEQxYMoWGpP_gO5y9pksp9eRIpfUPCiXkM2mdTY7aYk2y3-90YrBecw8-Axj8ePkEvOroEzUc21GTKALBf1CZkAgMhEWbLToy7gnMxi_GRp6oLXJUzI-0IF4_yoot51KlDjIqqI8zgEv0YaXFzTpNXgrNNp-566nhrELe1Qhd71K2qD2uDeh_UNVTTg6HB_Qc6s6iLO_u6UvD3cvy6esuXL4_PibplpUcOQ8apShbBtYaxAhZADx1w02BjkrC1Fk1vQRmiDqqpNVTfMaqiMzlnR_phiSm4Pudtdu0GjsU9dO7kNbqPCl_TKyf9O7z7kyo8yAeNFDk1KuDok6OBjDGiPz5zJX64ycZUAMnEV32tnbqg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Cardiovascular disease/stroke risk stratification in deep learning framework: a review</title><source>PubMed Central</source><creator>Bhagawati, Mrinalini ; Paul, Sudip ; Agarwal, Sushant ; Protogeron, Athanasios ; Sfikakis, Petros P. ; Kitas, George D. ; Khanna, Narendra N. ; Ruzsa, Zoltan ; Sharma, Aditya M. ; Tomazu, Omerzu ; Turk, Monika ; Faa, Gavino ; Tsoulfas, George ; Laird, John R. ; Rathore, Vijay ; Johri, Amer M. ; Viskovic, Klaudija ; Kalra, Manudeep ; Balestrieri, Antonella ; Nicolaides, Andrew ; Singh, Inder M. ; Chaturvedi, Seemant ; Paraskevas, Kosmas I. ; Fouda, Mostafa M. ; Saba, Luca ; Suri, Jasjit S.</creator><creatorcontrib>Bhagawati, Mrinalini ; Paul, Sudip ; Agarwal, Sushant ; Protogeron, Athanasios ; Sfikakis, Petros P. ; Kitas, George D. ; Khanna, Narendra N. ; Ruzsa, Zoltan ; Sharma, Aditya M. ; Tomazu, Omerzu ; Turk, Monika ; Faa, Gavino ; Tsoulfas, George ; Laird, John R. ; Rathore, Vijay ; Johri, Amer M. ; Viskovic, Klaudija ; Kalra, Manudeep ; Balestrieri, Antonella ; Nicolaides, Andrew ; Singh, Inder M. ; Chaturvedi, Seemant ; Paraskevas, Kosmas I. ; Fouda, Mostafa M. ; Saba, Luca ; Suri, Jasjit S.</creatorcontrib><description>The global mortality rate is known to be the highest due to cardiovascular disease (CVD). Thus, preventive, and early CVD risk identification in a non-invasive manner is vital as healthcare cost is increasing day by day. Conventional methods for risk prediction of CVD lack robustness due to the non-linear relationship between risk factors and cardiovascular events in multi-ethnic cohorts. Few recently proposed machine learning-based risk stratification reviews without deep learning (DL) integration. The proposed study focuses on CVD risk stratification by the use of techniques mainly solo deep learning (SDL) and hybrid deep learning (HDL). Using a PRISMA model, 286 DL-based CVD studies were selected and analyzed. The databases included were Science Direct, IEEE Xplore, PubMed, and Google Scholar. This review is focused on different SDL and HDL architectures, their characteristics, applications, scientific and clinical validation, along with plaque tissue characterization for CVD/stroke risk stratification. Since signal processing methods are also crucial, the study further briefly presented Electrocardiogram (ECG)-based solutions. Finally, the study presented the risk due to bias in AI systems. The risk of bias tools used were (I) ranking method (RBS), (II) region-based map (RBM), (III) radial bias area (RBA), (IV) prediction model risk of bias assessment tool (PROBAST), and (V) risk of bias in non-randomized studies-of interventions (ROBINS-I). The surrogate carotid ultrasound image was mostly used in the UNet-based DL framework for arterial wall segmentation. Ground truth (GT) selection is vital for reducing the risk of bias (RoB) for CVD risk stratification. It was observed that the convolutional neural network (CNN) algorithms were widely used since the feature extraction process was automated. The ensemble-based DL techniques for risk stratification in CVD are likely to supersede the SDL and HDL paradigms. Due to the reliability, high accuracy, and faster execution on dedicated hardware, these DL methods for CVD risk assessment are powerful and promising. The risk of bias in DL methods can be best reduced by considering multicentre data collection and clinical evaluation.</description><identifier>ISSN: 2223-3652</identifier><identifier>EISSN: 2223-3660</identifier><identifier>DOI: 10.21037/cdt-22-438</identifier><language>eng</language><publisher>AME Publishing Company</publisher><subject>Review</subject><ispartof>Cardiovascular diagnosis and therapy, 2023-06, Vol.12 (3), p.557-598</ispartof><rights>2023 Cardiovascular Diagnosis and Therapy. All rights reserved. 2023 Cardiovascular Diagnosis and Therapy.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c382t-177a53fb5df3eae2421e439e9de10b6394f2cd3cdea78d7890fc27dc405b394f3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315429/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315429/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids></links><search><creatorcontrib>Bhagawati, Mrinalini</creatorcontrib><creatorcontrib>Paul, Sudip</creatorcontrib><creatorcontrib>Agarwal, Sushant</creatorcontrib><creatorcontrib>Protogeron, Athanasios</creatorcontrib><creatorcontrib>Sfikakis, Petros P.</creatorcontrib><creatorcontrib>Kitas, George D.</creatorcontrib><creatorcontrib>Khanna, Narendra N.</creatorcontrib><creatorcontrib>Ruzsa, Zoltan</creatorcontrib><creatorcontrib>Sharma, Aditya M.</creatorcontrib><creatorcontrib>Tomazu, Omerzu</creatorcontrib><creatorcontrib>Turk, Monika</creatorcontrib><creatorcontrib>Faa, Gavino</creatorcontrib><creatorcontrib>Tsoulfas, George</creatorcontrib><creatorcontrib>Laird, John R.</creatorcontrib><creatorcontrib>Rathore, Vijay</creatorcontrib><creatorcontrib>Johri, Amer M.</creatorcontrib><creatorcontrib>Viskovic, Klaudija</creatorcontrib><creatorcontrib>Kalra, Manudeep</creatorcontrib><creatorcontrib>Balestrieri, Antonella</creatorcontrib><creatorcontrib>Nicolaides, Andrew</creatorcontrib><creatorcontrib>Singh, Inder M.</creatorcontrib><creatorcontrib>Chaturvedi, Seemant</creatorcontrib><creatorcontrib>Paraskevas, Kosmas I.</creatorcontrib><creatorcontrib>Fouda, Mostafa M.</creatorcontrib><creatorcontrib>Saba, Luca</creatorcontrib><creatorcontrib>Suri, Jasjit S.</creatorcontrib><title>Cardiovascular disease/stroke risk stratification in deep learning framework: a review</title><title>Cardiovascular diagnosis and therapy</title><description>The global mortality rate is known to be the highest due to cardiovascular disease (CVD). Thus, preventive, and early CVD risk identification in a non-invasive manner is vital as healthcare cost is increasing day by day. Conventional methods for risk prediction of CVD lack robustness due to the non-linear relationship between risk factors and cardiovascular events in multi-ethnic cohorts. Few recently proposed machine learning-based risk stratification reviews without deep learning (DL) integration. The proposed study focuses on CVD risk stratification by the use of techniques mainly solo deep learning (SDL) and hybrid deep learning (HDL). Using a PRISMA model, 286 DL-based CVD studies were selected and analyzed. The databases included were Science Direct, IEEE Xplore, PubMed, and Google Scholar. This review is focused on different SDL and HDL architectures, their characteristics, applications, scientific and clinical validation, along with plaque tissue characterization for CVD/stroke risk stratification. Since signal processing methods are also crucial, the study further briefly presented Electrocardiogram (ECG)-based solutions. Finally, the study presented the risk due to bias in AI systems. The risk of bias tools used were (I) ranking method (RBS), (II) region-based map (RBM), (III) radial bias area (RBA), (IV) prediction model risk of bias assessment tool (PROBAST), and (V) risk of bias in non-randomized studies-of interventions (ROBINS-I). The surrogate carotid ultrasound image was mostly used in the UNet-based DL framework for arterial wall segmentation. Ground truth (GT) selection is vital for reducing the risk of bias (RoB) for CVD risk stratification. It was observed that the convolutional neural network (CNN) algorithms were widely used since the feature extraction process was automated. The ensemble-based DL techniques for risk stratification in CVD are likely to supersede the SDL and HDL paradigms. Due to the reliability, high accuracy, and faster execution on dedicated hardware, these DL methods for CVD risk assessment are powerful and promising. The risk of bias in DL methods can be best reduced by considering multicentre data collection and clinical evaluation.</description><subject>Review</subject><issn>2223-3652</issn><issn>2223-3660</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNpVkM1LAzEQxYMoWGpP_gO5y9pksp9eRIpfUPCiXkM2mdTY7aYk2y3-90YrBecw8-Axj8ePkEvOroEzUc21GTKALBf1CZkAgMhEWbLToy7gnMxi_GRp6oLXJUzI-0IF4_yoot51KlDjIqqI8zgEv0YaXFzTpNXgrNNp-566nhrELe1Qhd71K2qD2uDeh_UNVTTg6HB_Qc6s6iLO_u6UvD3cvy6esuXL4_PibplpUcOQ8apShbBtYaxAhZADx1w02BjkrC1Fk1vQRmiDqqpNVTfMaqiMzlnR_phiSm4Pudtdu0GjsU9dO7kNbqPCl_TKyf9O7z7kyo8yAeNFDk1KuDok6OBjDGiPz5zJX64ycZUAMnEV32tnbqg</recordid><startdate>20230630</startdate><enddate>20230630</enddate><creator>Bhagawati, Mrinalini</creator><creator>Paul, Sudip</creator><creator>Agarwal, Sushant</creator><creator>Protogeron, Athanasios</creator><creator>Sfikakis, Petros P.</creator><creator>Kitas, George D.</creator><creator>Khanna, Narendra N.</creator><creator>Ruzsa, Zoltan</creator><creator>Sharma, Aditya M.</creator><creator>Tomazu, Omerzu</creator><creator>Turk, Monika</creator><creator>Faa, Gavino</creator><creator>Tsoulfas, George</creator><creator>Laird, John R.</creator><creator>Rathore, Vijay</creator><creator>Johri, Amer M.</creator><creator>Viskovic, Klaudija</creator><creator>Kalra, Manudeep</creator><creator>Balestrieri, Antonella</creator><creator>Nicolaides, Andrew</creator><creator>Singh, Inder M.</creator><creator>Chaturvedi, Seemant</creator><creator>Paraskevas, Kosmas I.</creator><creator>Fouda, Mostafa M.</creator><creator>Saba, Luca</creator><creator>Suri, Jasjit S.</creator><general>AME Publishing Company</general><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20230630</creationdate><title>Cardiovascular disease/stroke risk stratification in deep learning framework: a review</title><author>Bhagawati, Mrinalini ; Paul, Sudip ; Agarwal, Sushant ; Protogeron, Athanasios ; Sfikakis, Petros P. ; Kitas, George D. ; Khanna, Narendra N. ; Ruzsa, Zoltan ; Sharma, Aditya M. ; Tomazu, Omerzu ; Turk, Monika ; Faa, Gavino ; Tsoulfas, George ; Laird, John R. ; Rathore, Vijay ; Johri, Amer M. ; Viskovic, Klaudija ; Kalra, Manudeep ; Balestrieri, Antonella ; Nicolaides, Andrew ; Singh, Inder M. ; Chaturvedi, Seemant ; Paraskevas, Kosmas I. ; Fouda, Mostafa M. ; Saba, Luca ; Suri, Jasjit S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c382t-177a53fb5df3eae2421e439e9de10b6394f2cd3cdea78d7890fc27dc405b394f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Review</topic><toplevel>online_resources</toplevel><creatorcontrib>Bhagawati, Mrinalini</creatorcontrib><creatorcontrib>Paul, Sudip</creatorcontrib><creatorcontrib>Agarwal, Sushant</creatorcontrib><creatorcontrib>Protogeron, Athanasios</creatorcontrib><creatorcontrib>Sfikakis, Petros P.</creatorcontrib><creatorcontrib>Kitas, George D.</creatorcontrib><creatorcontrib>Khanna, Narendra N.</creatorcontrib><creatorcontrib>Ruzsa, Zoltan</creatorcontrib><creatorcontrib>Sharma, Aditya M.</creatorcontrib><creatorcontrib>Tomazu, Omerzu</creatorcontrib><creatorcontrib>Turk, Monika</creatorcontrib><creatorcontrib>Faa, Gavino</creatorcontrib><creatorcontrib>Tsoulfas, George</creatorcontrib><creatorcontrib>Laird, John R.</creatorcontrib><creatorcontrib>Rathore, Vijay</creatorcontrib><creatorcontrib>Johri, Amer M.</creatorcontrib><creatorcontrib>Viskovic, Klaudija</creatorcontrib><creatorcontrib>Kalra, Manudeep</creatorcontrib><creatorcontrib>Balestrieri, Antonella</creatorcontrib><creatorcontrib>Nicolaides, Andrew</creatorcontrib><creatorcontrib>Singh, Inder M.</creatorcontrib><creatorcontrib>Chaturvedi, Seemant</creatorcontrib><creatorcontrib>Paraskevas, Kosmas I.</creatorcontrib><creatorcontrib>Fouda, Mostafa M.</creatorcontrib><creatorcontrib>Saba, Luca</creatorcontrib><creatorcontrib>Suri, Jasjit S.</creatorcontrib><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cardiovascular diagnosis and therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bhagawati, Mrinalini</au><au>Paul, Sudip</au><au>Agarwal, Sushant</au><au>Protogeron, Athanasios</au><au>Sfikakis, Petros P.</au><au>Kitas, George D.</au><au>Khanna, Narendra N.</au><au>Ruzsa, Zoltan</au><au>Sharma, Aditya M.</au><au>Tomazu, Omerzu</au><au>Turk, Monika</au><au>Faa, Gavino</au><au>Tsoulfas, George</au><au>Laird, John R.</au><au>Rathore, Vijay</au><au>Johri, Amer M.</au><au>Viskovic, Klaudija</au><au>Kalra, Manudeep</au><au>Balestrieri, Antonella</au><au>Nicolaides, Andrew</au><au>Singh, Inder M.</au><au>Chaturvedi, Seemant</au><au>Paraskevas, Kosmas I.</au><au>Fouda, Mostafa M.</au><au>Saba, Luca</au><au>Suri, Jasjit S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cardiovascular disease/stroke risk stratification in deep learning framework: a review</atitle><jtitle>Cardiovascular diagnosis and therapy</jtitle><date>2023-06-30</date><risdate>2023</risdate><volume>12</volume><issue>3</issue><spage>557</spage><epage>598</epage><pages>557-598</pages><issn>2223-3652</issn><eissn>2223-3660</eissn><abstract>The global mortality rate is known to be the highest due to cardiovascular disease (CVD). Thus, preventive, and early CVD risk identification in a non-invasive manner is vital as healthcare cost is increasing day by day. Conventional methods for risk prediction of CVD lack robustness due to the non-linear relationship between risk factors and cardiovascular events in multi-ethnic cohorts. Few recently proposed machine learning-based risk stratification reviews without deep learning (DL) integration. The proposed study focuses on CVD risk stratification by the use of techniques mainly solo deep learning (SDL) and hybrid deep learning (HDL). Using a PRISMA model, 286 DL-based CVD studies were selected and analyzed. The databases included were Science Direct, IEEE Xplore, PubMed, and Google Scholar. This review is focused on different SDL and HDL architectures, their characteristics, applications, scientific and clinical validation, along with plaque tissue characterization for CVD/stroke risk stratification. Since signal processing methods are also crucial, the study further briefly presented Electrocardiogram (ECG)-based solutions. Finally, the study presented the risk due to bias in AI systems. The risk of bias tools used were (I) ranking method (RBS), (II) region-based map (RBM), (III) radial bias area (RBA), (IV) prediction model risk of bias assessment tool (PROBAST), and (V) risk of bias in non-randomized studies-of interventions (ROBINS-I). The surrogate carotid ultrasound image was mostly used in the UNet-based DL framework for arterial wall segmentation. Ground truth (GT) selection is vital for reducing the risk of bias (RoB) for CVD risk stratification. It was observed that the convolutional neural network (CNN) algorithms were widely used since the feature extraction process was automated. The ensemble-based DL techniques for risk stratification in CVD are likely to supersede the SDL and HDL paradigms. Due to the reliability, high accuracy, and faster execution on dedicated hardware, these DL methods for CVD risk assessment are powerful and promising. The risk of bias in DL methods can be best reduced by considering multicentre data collection and clinical evaluation.</abstract><pub>AME Publishing Company</pub><doi>10.21037/cdt-22-438</doi><tpages>42</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2223-3652 |
ispartof | Cardiovascular diagnosis and therapy, 2023-06, Vol.12 (3), p.557-598 |
issn | 2223-3652 2223-3660 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10315429 |
source | PubMed Central |
subjects | Review |
title | Cardiovascular disease/stroke risk stratification in deep learning framework: a review |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T02%3A52%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cardiovascular%20disease/stroke%20risk%20stratification%20in%20deep%20learning%20framework:%20a%20review&rft.jtitle=Cardiovascular%20diagnosis%20and%20therapy&rft.au=Bhagawati,%20Mrinalini&rft.date=2023-06-30&rft.volume=12&rft.issue=3&rft.spage=557&rft.epage=598&rft.pages=557-598&rft.issn=2223-3652&rft.eissn=2223-3660&rft_id=info:doi/10.21037/cdt-22-438&rft_dat=%3Cpubmedcentral_cross%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_10315429%3C/pubmedcentral_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c382t-177a53fb5df3eae2421e439e9de10b6394f2cd3cdea78d7890fc27dc405b394f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |